LENZ Therapeutics competes within the specialized ophthalmic drug development sector against established pharmaceutical competitors marketing pharmacological treatments for presbyopia. Key market rivals include Orasis Pharmaceuticals (developer of pilocarpine-based Qlosi) and AbbVie subsidiary Allergan (developer of Vuity), which vie for market share in the growing non-invasive vision correction therapeutic space.